In ₹ Crore except Per Share Latest Annual	UNICHEMLAB FY26	GUFICBIO FY26	RPGLIFE FY26	GUJTHEM FY26	Peer Average
Valuation — at last close
P/E	◆ 13.61×	66.21×	157.30×	83.07×	102.19× -87%
P/B	◆ 1.27×	6.39×	7.77×	13.46×	9.21× -86%
EV/EBITDA	◆ 19.63×	30.12×	30.24×	53.33×	37.90× -48%
Market Cap	₹3,441 Cr	₹4,249 Cr	₹4,703 Cr	₹3,874 Cr	₹4,276 Cr -20%
Growth
Revenue CAGR 3Y	17.91%	—	—	—	—
Revenue CAGR 5Y	12.26%	—	—	—	—
Revenue YoY (latest Q)	20.13%	16.58%	—	◆ 22.07%	19.32% +4%
Net Income YoY (latest Q)	◆ 496.08%	70.71%	—	22.12%	46.41% +969%
Profitability
EBITDA Margin	8.36%	16.03%	20.79%	◆ 45.55%	27.46% -70%
Net Income Margin	11.48%	6.80%	16.28%	◆ 28.15%	17.08% -33%
Return on Common Equity	9.78%	10.14%	◆ 20.28%	17.41%	15.94% -39%
Return on Capital Employed	2.18%	15.00%	◆ 21.46%	17.76%	18.07% -88%
Return on Assets	6.92%	5.11%	◆ 15.88%	11.60%	10.86% -36%
Credit & Quality
Total Debt/Equity	0.17×	0.58×	◆ 0.03×	0.56×	0.39× -56%
Interest Coverage	1.87×	3.29×	◆ 141.13×	21.23×	55.22× -97%
Scale — latest FY
Revenue / Total Income	₹2,202 Cr	₹944 Cr	₹708 Cr	₹166 Cr	₹606 Cr +263%
Net Income	₹253 Cr	₹64.2 Cr	₹115 Cr	₹46.7 Cr	₹75.4 Cr +236%
Total Assets	₹3,737 Cr	₹1,342 Cr	₹793 Cr	₹503 Cr	₹880 Cr +325%
EPS	₹35.91	₹6.4	₹18.08	₹4.28	₹9.59 +275%
Book Value per Share	₹386	₹66.31	₹366.07	₹26.41	₹152.93 +152%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.